ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

12,531Medicare Part D Prescriptions Filled, Including Refills
$1.91M Total Retail Price of All Prescriptions
694 Patients Receiving at Least One Drug in Part D
22%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
RISPERIDONE 1,056 159
ABILIFY 545 87
TRAZODONE HCL 522 40
MIRTAZAPINE 501 151
OLANZAPINE 434 40
BENZTROPINE MESYLATE 419 18 R
VENLAFAXINE HCL ER 394 22
CLOZAPINE 390 17
FLUOXETINE HCL 360 44
QUETIAPINE FUMARATE 318 0
SERTRALINE HCL 318 31
LAMOTRIGINE 317 31
CITALOPRAM HBR 307 63
CYMBALTA 285 76
ESCITALOPRAM OXALATE 263 66
DIVALPROEX SODIUM ER 262 21
BUSPIRONE HCL 233 56
PAROXETINE HCL 227 21
HALOPERIDOL 215 0
ZIPRASIDONE HCL 213 0
DOXEPIN HCL 209 0
PRISTIQ ER 207 36
BUPROPION XL 198 11
INVEGA 195 15
FLUVOXAMINE MALEATE 190 27
LITHIUM CARBONATE 158 0
SEROQUEL 153 0
NALTREXONE HCL 136 0 10
BUPROPION HCL SR 133 15
HYDROXYZINE PAMOATE 132 0 R
SEROQUEL XR 124 21
DONEPEZIL HCL 121 85
ZYPREXA 117 0
OXCARBAZEPINE 115 12
GABAPENTIN 109 22
TRIHEXYPHENIDYL HCL 107 0 R
TOPIRAMATE 106 0
AMITRIPTYLINE HCL 102 13 R
PROPRANOLOL HCL 98 0
DIVALPROEX SODIUM 96 26
EXELON 87 87
INVEGA SUSTENNA 86 0
AMPHETAMINE SALT COMBO 75 13 S2
HYDROXYZINE HCL 72 0 R
NAMENDA 64 63
PERPHENAZINE 63 0
CHLORPROMAZINE HCL 61 0
LEXAPRO 60 14
RISPERDAL CONSTA 59 23
PRAZOSIN HCL 56 0
FLUPHENAZINE DECANOATE 55 0
VALPROIC ACID 55 30
CARBAMAZEPINE 55 0
GEODON 53 0
HALOPERIDOL DECANOATE 100 52 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.